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the ecologic system could contribute 
to the emergence of human leishmani-
asis in urban areas. 
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TaqMan Assay for 
Swedish Chlamydia 
trachomatis Variant
To the Editor:  Chlamydia tra-
chomatis (CT) is the most prevalent 
bacterial sexually transmitted infection 
worldwide. Recently, a new variant of 
CT (swCT) has been reported in Hal-
land County, Sweden. A total of 12 
swCT specimens were sequenced and 
found to have the same deletion, a 377-
bp deletion in the cryptic plasmid (1). 
Because the deletion was found in the 
target area of 2 commercial CT nucleic 
acid ampliﬁ  cation tests (Roche, Basel, 
Switzerland, and Abbott Laboratories, 
Abbott Park, IL, USA), screening tests 
have produced false-negative results 
for patients infected with this new 
Swedish variant (1). In speciﬁ  c  re-
gions of Sweden, the proportion of all 
detected CT cases attributable to swCT 
ranges from 13% to 39%; a consider-
able number of chlamydia infections 
have escaped detection by commonly 
used test systems (1).
Although the ﬁ   rst 2 studies to 
monitor potential spread of the swCT 
variant outside Sweden (Ireland and 
the Netherlands) did not detect swCT, 
a third study (Norway) did identify 
this variant (2–4). Subsequently, the 
European Surveillance of Sexually 
Transmitted Infections network and 
the European Center for Disease Pre-
vention and Control launched an ini-
tiative, consisting of a short question-
naire, to learn more about this swCT 
variant problem outside Sweden (5).
However, quick monitoring of the 
spread of the swCT variant has been 
hampered by lack of a direct test to 
detect this swCT variant and by lack 
of a readily available positive control. 
We therefore constructed a positive 
control by using a clinical specimen of 
the swCT variant in which the deletion 
was present (forward swCT 5′-TCC 
GGA TAG TGA ATT ATA GAG ACT 
ATT TAA TC-3′ reverse swCT 5′GGT 
GTT TGT ACT AGA GGA CTT ACC 
TCT TC-3′) (2). The specimen was 
obtained in Sweden (by B.H.) and 
conﬁ  rmed as swCT by the method de-
scribed by Ripa and Nilsson (6). The 
obtained 98-bp amplicon was sub-
sequently cloned in a pGEM-T Easy 
Vector (Promega Benelux b.v., Leiden, 
the Netherlands) and transformed in 
Escherichia coli DH5α. After extrac-
tion the plasmid was veriﬁ  ed for the 
correct insert by sequencing and quan-
tiﬁ  ed as described (7). This positive 
control is available for researchers and 
clinicians free of charge.
Subsequently, we developed a 
real-time PCR (TaqMan assay) that 
speciﬁ  cally detects the swCt variant 
by using a probe that spans the 377-
bp left and right gap border sequences: 
probe- swCT 5′-FAM GGA TCC GTT 
TGT TCT GG MGB -3′. One copy of 
cloned positive swCT control could 
be detected in our swCT assay. We se-
lected 10 copies per PCR as positive 
swCT control for each run. A total of 
239 recent samples known to be CT 
positive and identiﬁ  ed with techniques 
detecting the swCT variant were ret-
rospectively analyzed with our new 
swCT real-time PCR for 3 cohorts: 1) 
30 real-time PCR CT-positive clinical 
samples (CT prevalence in the popu-
lation, 1.8%) from the Department of 
Medical Microbiology and Infection 
Prevention, VU University Medical 
Center, Amsterdam, the Netherlands; 
2) 57 Becton Dickinson (Franklin 
Lakes, NJ, USA) CT-positive samples 
(CT prevalence in the sexually trans-
mitted disease population, 7.3%) from 
the Department of Infectious Diseases, 
South Limburg Public Health Service, 
Heerlen, the Netherlands; and 3) 152 LETTERS
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CT-positive culture samples (CT prev-
alence in the population, average 15% 
[8]) from the Faculty of Medicine, St. 
Petersburg State University, St. Peters-
burg, Russia, and from the Laboratory 
of Microbiology, D.O. Ott Research 
Institute of Obstetrics and Gynaecol-
ogy, St. Petersburg, Russia.
Cohort 1 consisted of cervical 
swabs in 2-sucrose-phosphate (2SP) 
transport medium, stored at –80°C. 
Cohort 2 consisted of frozen dry 
swabs that had been shaken for 10 s 
in 1 mL 2SP transport medium before 
sample preparation. Cohort 3 con-
sisted of positive cultured samples. 
DNA extraction used 200 μL 2SP and 
was performed with the NucliSens 
easyMAG (bioMérieux, Boxtel, the 
Netherlands); the DNA was eluted in 
110 μL 2SP (7). Presence of CT DNA 
was reconﬁ  rmed for all samples with 
our in-house PCR. Sensitivity of this 
assay was determined by using a previ-
ously described serial dilution of lym-
phogranuloma venereum (LGV) strain 
L2 and was assessed at 0.01 inclusion-
forming units (9). Ampliﬁ  cation and 
detection were performed with an ABI 
Prism 7000 sequence detection system 
(Applied Biosystems, Foster City, CA, 
USA) by standard PCR conditions of 
the manufacturer, with 45 cycles. The 
Swedish variant was found in none of 
the 3 cohorts tested. Sensitivity and 
speciﬁ  city were conﬁ  rmed by using 12 
swCT variant samples from Sweden, 
which were all positive according to 
our swCT TaqMan assay.
Our new swCT TaqMan assay, 
combined with the positive control 
(which can be obtained by contacting 
S.M.), will be a helpful tool for deter-
mining whether this Swedish CT vari-
ant is present outside Sweden, other 
than in the 2 case-patients identiﬁ  ed in 
Norway. We did not ﬁ  nd any evidence 
of the swCT variant in the Netherlands 
or St. Petersburg, Russia, each of 
which is near Scandinavia (Table). Re-
cently, the C. trachomatis LGV strain 
was discovered in the Netherlands in a 
population of men who have sex with 
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men. In this instance, the real-time 
TaqMan assay also proved helpful in 
determining spread (10). 
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Highly Pathogenic 
Porcine 
Reproductive and 
Respiratory 
Syndrome, China
To the Editor: Since April 2006, 
a highly pathogenic disease caused by 
unknown agents and characterized by 
high fever and a high proportion of 
deaths in pigs of all ages, emerged in 
some swine farms in Jiangxi Province, 
People’s Republic of China. The mor-
bidity rate was 50%–100% and mor-
tality rate was 20%–100%. In the next 
several months, the disease spread 
rapidly to most provinces of China. 
In almost all affected swine herds, 
the following clinical signs were ob-
served: high and continuous fever, an-
orexia, red discolorations in the bod-
ies, and blue ears; in the late phase of 
the disease, diarrhea and other clinical 
signs might be seen due to the sec-
ondary infections. Clinical samples 
(from lungs, kidneys, liver, and lymph 
nodes) were collected from animals in 
different provinces and sent for labo-
ratory diagnosis. DNA and RNA were 
extracted from the tissue homogenate 
and PCR or reverse transcription–
PCR (RT-PCR) was conducted to de-
tect porcine reproductive and respira-
tory syndrome virus (PRRSV), classic 
swine fever virus, porcine circovirus, 
and pseudorabies virus, respectively 
(1). In clinical samples, only PRRSV 
was found to be the dominant virus 
(48 of 50 samples were PRRSV posi-
Table. Published studies and the current study on screening for the swCT variant* 
Location
Ct+,
no. detected 
swCT variant,  
no. detected  Reference
Amsterdam, the Netherlands   75 ND (3)
Dublin, Ireland  750 ND (4)
Oslo, Norway†  47 2 (5)
St. Petersburg, Russia  152 ND This study 
Heerlen, the Netherlands  57 ND This study 
Amsterdam, the Netherlands  30 ND This study 
*swCT, Swedish Chlamydia trachomatis variant identified in Halland County, Sweden; Ct+, C.
trachomatis DNA; ND, not detected.  
†2 female patients: 1 originally from Sweden, 1 from Norway. 
1These authors contributed equally to the 
study.